Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-7022
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury ; volume:4 ; number:3 ; day:18 ; month:7 ; year:2014 ; pages:1 ; date:7.2014
Clinical and translational allergy ; 4, Heft 3 (18.7.2014), 1, 7.2014
- Urheber
-
Usui, Toru
Saide, Katy
Meng, Xiaoli
Whitaker, Paul
Peckham, Daniel
French, Neil
Naisbitt, Dean
Park, Kevin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2045-7022-4-S3-P116
- URN
-
urn:nbn:de:101:1-2019102904153558164198
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Usui, Toru
- Saide, Katy
- Meng, Xiaoli
- Whitaker, Paul
- Peckham, Daniel
- French, Neil
- Naisbitt, Dean
- Park, Kevin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of isoniazid-resistant pulmonary tuberculosis
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
First identification of marine diatoms with anti-tuberculosis activity
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)
Antituberculosis drugs
Treatment of isoniazid-resistant pulmonary tuberculosis
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
First identification of marine diatoms with anti-tuberculosis activity
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)
Antituberculosis drugs
Treatment of isoniazid-resistant pulmonary tuberculosis
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
First identification of marine diatoms with anti-tuberculosis activity
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)